Jiangsu Yahong Meditech Co., Ltd.SSE: 688176

Announcement on Convening the Q3 2025 Performance Briefing

Nov 20, 2025 · Issued by Jiangsu Yahong Meditech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 20, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2025-performance-briefing-736

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Jiangsu Yahong Meditech Co., Ltd. on 6ix

Earlier from Jiangsu Yahong Meditech

Announcement on Completing Changes in Registered Capital and Obtaining Renewed Business LicenseNov 15, 2025
Announcement on Election of Employee Directors for the 2nd Board of Directors and Appointment of Senior Management MembersOct 30, 2025
Announcement on Voluntary Disclosure of Publication of Relevant Data from the APL-1702 International Multicenter Phase 3 Clinical Trial in the International Journal "Med"Oct 11, 2025
Announcement on Departure of Company Director and Senior Management MemberOct 1, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Sep 24, 2025

Later from Jiangsu Yahong Meditech

Announcement on Changing Signatory Certified Public AccountantNov 29, 2025
Announcement on Voluntary Disclosure of the Release of APL-1401 Phase Ib Clinical Trial Data at the 19th European Colorectal Congress (ECC)Dec 4, 2025
Announcement on Voluntary Disclosure of Clinical Trial Applications for APL-2401 Approved by China NMPADec 18, 2025
Announcement on Voluntary Disclosure of Acceptance of APLD-2304 for European Medical Device RegistrationDec 22, 2025
Announcement on Voluntary Disclosure of Completion of 1st Subject Enrollment in Phase 1 Clinical Trial of APL-2401Jan 9

All Jiangsu Yahong Meditech news releases

Follow Jiangsu Yahong Meditech into a list and get an email when it puts out news.

Follow Jiangsu Yahong Meditech